关注
Françoise Rothé
Françoise Rothé
Breast Cancer Translational Research Laboratory, Institut Jules Bordet
在 bordet.be 的电子邮件经过验证
标题
引用次数
引用次数
年份
CD4+ follicular helper T cell infiltration predicts breast cancer survival
C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ...
The Journal of clinical investigation 123 (7), 2873-2892, 2013
10522013
Human natural Treg microRNA signature: role of microRNA‐31 and microRNA‐21 in FOXP3 expression
R Rouas, H Fayyad‐Kazan, N El Zein, P Lewalle, F Rothé, A Simion, ...
European journal of immunology 39 (6), 1608-1618, 2009
3482009
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
Y Bareche, D Venet, M Ignatiadis, P Aftimos, M Piccart, F Rothe, ...
Annals of oncology 29 (4), 895-902, 2018
3332018
Genomic characterization of primary invasive lobular breast cancer
C Desmedt, G Zoppoli, G Gundem, G Pruneri, D Larsimont, M Fornili, ...
Journal of clinical oncology 34 (16), 1872-1881, 2016
3112016
Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer
F Rothe, M Ignatiadis, C Chaboteaux, B Haibe-Kains, N Kheddoumi, ...
PloS one 6 (6), e20980, 2011
2772011
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
F Rothé, JF Laes, D Lambrechts, D Smeets, D Vincent, M Maetens, ...
Annals of oncology 25 (10), 1959-1965, 2014
2702014
Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: a meta-analysis
FC Bidard, S Michiels, S Riethdorf, V Mueller, LJ Esserman, A Lucci, ...
JNCI: Journal of the National Cancer Institute 110 (6), 560-567, 2018
2692018
Immune evasion before tumour invasion in early lung squamous carcinogenesis
C Mascaux, M Angelova, A Vasaturo, J Beane, K Hijazi, G Anthoine, ...
Nature 571 (7766), 570-575, 2019
2602019
DNA methylation profiling reveals a predominant immune component in breast cancers
S Dedeurwaerder, C Desmedt, E Calonne, SK Singhal, B Haibe‐Kains, ...
EMBO molecular medicine 3 (12), 726-741, 2011
2382011
HER2-positive circulating tumor cells in breast cancer
M Ignatiadis, F Rothe, C Chaboteaux, V Durbecq, G Rouas, C Criscitiello, ...
PloS one 6 (1), e15624, 2011
2242011
Principles governing A-to-I RNA editing in the breast cancer transcriptome
D Fumagalli, D Gacquer, F Rothé, A Lefort, F Libert, D Brown, ...
Cell reports 13 (2), 277-289, 2015
2122015
Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer
FW Hunter, HR Barker, B Lipert, F Rothé, G Gebhart, MJ Piccart-Gebhart, ...
British journal of cancer 122 (5), 603-612, 2020
2092020
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
DJE Peeters, B De Laere, GG Van den Eynden, SJ Van Laere, F Rothé, ...
British journal of cancer 108 (6), 1358-1367, 2013
1822013
Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
D Brown, D Smeets, B Székely, D Larsimont, AM Szász, PY Adnet, ...
Nature communications 8 (1), 14944, 2017
1702017
Unraveling triple-negative breast cancer tumor microenvironment heterogeneity: towards an optimized treatment approach
Y Bareche, L Buisseret, T Gruosso, E Girard, D Venet, F Dupont, ...
JNCI: Journal of the National Cancer Institute 112 (7), 708-719, 2020
1492020
RNA sequencing to predict response to neoadjuvant anti-HER2 therapy: a secondary analysis of the NeoALTTO randomized clinical trial
D Fumagalli, D Venet, M Ignatiadis, HA Azim, M Maetens, F Rothé, ...
JAMA oncology 3 (2), 227-234, 2017
1362017
Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer
L Buisseret, C Desmedt, S Garaud, M Fornili, X Wang, G Van den Eyden, ...
Modern Pathology 30 (9), 1204-1212, 2017
1132017
Immune infiltration in invasive lobular breast cancer
C Desmedt, R Salgado, M Fornili, G Pruneri, G Van den Eynden, ...
JNCI: Journal of the National Cancer Institute 110 (7), 768-776, 2018
1122018
Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer
A Hamm, H Prenen, W Van Delm, M Di Matteo, M Wenes, E Delamarre, ...
Gut 65 (6), 990-1000, 2016
1042016
Circulating tumor DNA in HER2-amplified breast cancer: a translational research substudy of the NeoALTTO phase III trial
F Rothé, MJ Silva, D Venet, C Campbell, I Bradburry, G Rouas, ...
Clinical cancer research 25 (12), 3581-3588, 2019
962019
系统目前无法执行此操作,请稍后再试。
文章 1–20